Status:

COMPLETED

VEGF Early Imaging for Breast Cancer

Lead Sponsor:

University Medical Center Groningen

Conditions:

Breast Cancer

Eligibility:

All Genders

18+ years

Phase:

EARLY_PHASE1

Brief Summary

Breast cancer is the most common cause of cancer death among women. Yearly around 12,500 Dutch women are diagnosed with breast cancer and 3,500 die of this disease. One of the problems leading to such...

Detailed Description

Objectives of the trial Primary objective The aim is to perform a feasibility study to show that VEGF PET imaging using 89Zr-bevacizumab as tracer can be used for early breast cancer detection. Seco...

Eligibility Criteria

Inclusion

  • Patients with a breast tumor size \< 2 cm in diameter (as determined by means of conventional imaging techniques: mammography, ultrasound or MRI) who are scheduled to receive operative intervention either by means of a mastectomy or lumpectomy.
  • histologically proven breast cancer
  • Age \> 18 years.
  • WHO performance status 0-2 (see: appendix B)
  • Signed written informed consent (approved by the Institutional Review Board \[IRB\]/ Independent Ethics Committee \[IEC\]) obtained prior to any study specific screening procedures.
  • Able to comply with the protocol.

Exclusion

  • Other invasive malignancy or condition which could affect compliance with the protocol or interpretation of results.
  • Pregnant or lactating women. Documentation of a negative pregnancy test must be available for pre-menopausal women with intact reproductive organs and for women less than two years after menopause.
  • Prior radiotherapy on the involved area.
  • Major surgery within 28 days before the initiation of the study.
  • Clinically significant cardiovascular disease.
  • Prior allergic reaction to immunoglobulins or immunoglobulin allergy.

Key Trial Info

Start Date :

March 1 2010

Trial Type :

INTERVENTIONAL

Allocation :

ACTUAL

End Date :

January 1 2012

Estimated Enrollment :

23 Patients enrolled

Trial Details

Trial ID

NCT00991978

Start Date

March 1 2010

End Date

January 1 2012

Last Update

March 30 2012

Active Locations (1)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 1 (1 locations)

1

Universitar Medical Center Groningen

Groningen, Provincie Groningen, Netherlands, 9713GZ